8don MSN
Novo Nordisk’s Wegovy head start on pills forces investors to rethink Eli Lilly's GLP-1 dominance
Early signs from the launch of Novo Nordisk's Wegovy pill and Eli Lilly & Co.'s Foundayo are making investors rethink the ...
As Eli Lilly gets off to the races with the launch of its flagship oral GLP-1 Foundayo, the Indianapolis drugmaker—and at ...
Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results